Saudi - Delayed Quote SAR

National Medical Care Company (4005.SR)

183.60 -3.20 (-1.71%)
At close: April 25 at 3:13 PM GMT+3
Key Events
Loading Chart for 4005.SR
DELL
  • Previous Close 186.80
  • Open 186.00
  • Bid 184.80 x --
  • Ask 185.00 x --
  • Day's Range 181.60 - 187.60
  • 52 Week Range 90.90 - 224.00
  • Volume 132,488
  • Avg. Volume 110,738
  • Market Cap (intraday) 8.234B
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) 34.25
  • EPS (TTM) 5.36
  • Earnings Date May 13, 2024 - May 17, 2024
  • Forward Dividend & Yield 1.00 (0.54%)
  • Ex-Dividend Date Jun 20, 2023
  • 1y Target Est 200.60

National Medical Care Company establishes, own, equips, manages, maintains, and operates healthcare facilities in the Kingdom of Saudi Arabia. The company operates Riyadh Care Hospital, Family Health Care Center, National Hospital, and Care Company for Pharmaceutical and Medical Distribution. It also provides home healthcare services. The company was founded in 2003 and is based in Riyadh, the Kingdom of Saudi Arabia.

www.care.med.sa

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 4005.SR

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

4005.SR
5.28%
Tadawul All Shares Index
2.70%

1-Year Return

4005.SR
106.13%
Tadawul All Shares Index
9.77%

3-Year Return

4005.SR
231.16%
Tadawul All Shares Index
20.92%

5-Year Return

4005.SR
306.47%
Tadawul All Shares Index
32.66%

Compare To: 4005.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4005.SR

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    8.23B

  • Enterprise Value

    7.87B

  • Trailing P/E

    34.19

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.61

  • Price/Book (mrq)

    5.67

  • Enterprise Value/Revenue

    7.28

  • Enterprise Value/EBITDA

    24.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.27%

  • Return on Assets (ttm)

    7.85%

  • Return on Equity (ttm)

    17.73%

  • Revenue (ttm)

    1.08B

  • Net Income Avi to Common (ttm)

    240.93M

  • Diluted EPS (ttm)

    5.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    693.67M

  • Total Debt/Equity (mrq)

    22.72%

  • Levered Free Cash Flow (ttm)

    347.12M

Research Analysis: 4005.SR

Analyst Price Targets

180.00
200.60 Average
183.60 Current
230.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: 4005.SR

People Also Watch